Related Experiment Videos
An update of immunotherapy for specific allergies
Susan L Prescott1, Catherine A Jones
1Department of Paediatrics, University of Western Australia, Princess Margaret Hospital, PO Box D184, Perth, Western Australia 6001. susanp@ichr.uwa.edu.au
Current Drug Targets. Inflammation and Allergy
|October 17, 2003
Summary
Allergen immunotherapy offers long-term relief from allergic diseases by modifying immune responses. New techniques and targets are advancing this treatment, aiming for prevention of allergies.
Area of Science:
- Immunology
- Allergy Research
- Therapeutic Development
Background:
- Allergic diseases are prevalent, debilitating, and potentially fatal.
- Current treatments for allergies are limited, but advances offer new therapeutic targets.
- Understanding the complex mechanisms of allergen-specific IgE production is crucial.
Purpose of the Study:
- To review recent developments and future directions in allergen immunotherapy.
- To discuss molecular mechanisms and novel techniques in immunotherapy.
- To explore adjunctive therapies and non-allergen specific molecular targets.
Main Methods:
- Review of current literature on allergen immunotherapy.
- Analysis of molecular mechanisms underlying immunotherapy.
- Discussion of emerging techniques such as allergen modification, gene vaccination, CpG immunostimulation, and peptide immunotherapy.
Main Results:
- Allergen immunotherapy can permanently modify allergic immune responses, leading to long-term symptom alleviation.
- Novel approaches like allergen modification and peptide immunotherapy show promise.
- Targeting non-allergen specific molecules may complement immunotherapy.
Conclusions:
- Advances in understanding allergic diseases are leading to improved immunotherapy strategies.
- Future directions include refining existing methods and developing new therapeutic targets.
- The ultimate goal is the prevention of allergic responses (immunoprophylaxis).